Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex Dosages for Neuromonitoring in Thyroid Surgery
NCT03689413Completed
- Sponsor
- Seoul National University Hospital
- Start
- Oct 2018
- Primary completion
- Aug 2019
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Sugammadex (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Quality of signal of neuromonitoring. Started Oct 2018; status: completed.
02
Drugs
Sugammadex
Beyond the preview
Go deeper on NCT03689413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03689413.